(0.35g*75 Tablets*5 boxes/lot). Tong Sai Mai Pian for mild to moderate atherosclerotic thrombotic cerebral infarction, toxic fever of thromboangiitis. Tongsaimai Tablets. Tongsaimai Pian
(0.35g*75 Tablets*5 boxes/lot). Tong Sai Mai Pian for mild to moderate atherosclerotic thrombotic cerebral infarction, toxic fever of thromboangiitis. Tongsaimai Tablets. Tongsaimai Pian
通常価格
$79.00 USD
通常価格
セール価格
$79.00 USD
単価
あたり
配送料はチェックアウト時に計算されます。
受取状況を読み込めませんでした
Generic name: Tongsaimai tablets
Chinese Pinyin: Tongsaimai Pian
Product name: Kangyuan
Ingredients: Angelica, Achyranthes, Astragalus, Codonopsis, Dendrobium, Scrophulariaceae, Honeysuckle, Licorice.
Properties: This product is a film-coated tablet, which is brown after removing the coating; sweet, slightly bitter, astringent
Functions and indications: Promoting blood circulation, clearing collaterals, replenishing qi and nourishing yin. Used for mild to moderate atherosclerotic thrombotic cerebral infarction (ischemic stroke in the meridian) recovery period Qi deficiency and blood stasis syndrome, symptoms manifested as hemiplegia, partial numbness, crooked mouth and eyes, poor speech, decreased or disappeared limb sensation Etc.; used for toxic fever of thromboangiitis (out of gangrene).
Specification: 0.35g*15 pieces/plate*5 plates/box
Usage and dosage: Oral. For the treatment of Qi deficiency and blood stasis syndrome during the recovery period of ischemic stroke, 5-6 tablets each time, 3 times a day; for thromboangiitis, 5-6 tablets each time, 3 times a day.
Adverse reactions: Unclear.
Taboo: Not clear yet.
Note: 1. Use with caution if thromboangiitis belongs to Yin-cold syndrome.
2. Diabetics should pay attention to monitoring the changes in blood sugar when using it; patients with fatty liver should pay attention to monitoring ALT.
Pharmacology and Toxicology: Pharmacodynamic test results show that this product can reduce the behavioral score, cerebral infarction rate, and cerebral water content of rats with focal cerebral ischemia caused by middle cerebral artery occlusion; it can make the acute blood stasis model larger The mouse’s auricle blood flow speed is accelerated, and it has a certain effect on improving hemorheology; it can increase the blood flow speed of the auricle of normal mice; it can also make the eyeball conjunctiva of rabbits with acute microcirculation disorder caused by polymer dextran micro Circulating blood flow speeds up.
Storage: sealed.
Packaging: Aluminum-plastic packaging, 15 pieces/plate*5 plates/box.
Validity period: 24 months
Approval number: National Medicine Standard Z32020535
Company Name: Jiangsu Nanxing Pharmaceutical Co., Ltd.
Company Address: No. 29, Hengjing Road, Nanjing Economic and Technological Development Zone
詳細を表示する
Chinese Pinyin: Tongsaimai Pian
Product name: Kangyuan
Ingredients: Angelica, Achyranthes, Astragalus, Codonopsis, Dendrobium, Scrophulariaceae, Honeysuckle, Licorice.
Properties: This product is a film-coated tablet, which is brown after removing the coating; sweet, slightly bitter, astringent
Functions and indications: Promoting blood circulation, clearing collaterals, replenishing qi and nourishing yin. Used for mild to moderate atherosclerotic thrombotic cerebral infarction (ischemic stroke in the meridian) recovery period Qi deficiency and blood stasis syndrome, symptoms manifested as hemiplegia, partial numbness, crooked mouth and eyes, poor speech, decreased or disappeared limb sensation Etc.; used for toxic fever of thromboangiitis (out of gangrene).
Specification: 0.35g*15 pieces/plate*5 plates/box
Usage and dosage: Oral. For the treatment of Qi deficiency and blood stasis syndrome during the recovery period of ischemic stroke, 5-6 tablets each time, 3 times a day; for thromboangiitis, 5-6 tablets each time, 3 times a day.
Adverse reactions: Unclear.
Taboo: Not clear yet.
Note: 1. Use with caution if thromboangiitis belongs to Yin-cold syndrome.
2. Diabetics should pay attention to monitoring the changes in blood sugar when using it; patients with fatty liver should pay attention to monitoring ALT.
Pharmacology and Toxicology: Pharmacodynamic test results show that this product can reduce the behavioral score, cerebral infarction rate, and cerebral water content of rats with focal cerebral ischemia caused by middle cerebral artery occlusion; it can make the acute blood stasis model larger The mouse’s auricle blood flow speed is accelerated, and it has a certain effect on improving hemorheology; it can increase the blood flow speed of the auricle of normal mice; it can also make the eyeball conjunctiva of rabbits with acute microcirculation disorder caused by polymer dextran micro Circulating blood flow speeds up.
Storage: sealed.
Packaging: Aluminum-plastic packaging, 15 pieces/plate*5 plates/box.
Validity period: 24 months
Approval number: National Medicine Standard Z32020535
Company Name: Jiangsu Nanxing Pharmaceutical Co., Ltd.
Company Address: No. 29, Hengjing Road, Nanjing Economic and Technological Development Zone
